{"result": "(\"entity\"<|>EUROPA<|>GEO<|>Europa is a continent where the prevalence of disease-related malnutrition (DRE) is a significant public health issue, with an estimated 33 million people at risk of malnutrition.)\n##\n(\"entity\"<|>ESPAÑA<|>GEO<|>Spain is a country in Europe where 24% of hospitalized patients are at risk of malnutrition, with costs associated with DRE estimated at 1143 million euros.)\n##\n(\"entity\"<|>PREDYCES<|>EVENT<|>The PREDYCES study demonstrated the prevalence of malnutrition and its associated risk factors among hospitalized patients in Spain.)\n##\n(\"entity\"<|>SNO<|>ORGANIZATION<|>SNO refers to oral nutritional supplements that can improve the nutritional status and quality of life of malnourished patients.)\n##\n(\"entity\"<|>CAWOOD ET AL.<|>PERSON<|>Cawood et al. conducted a systematic review showing that hyperproteic SNO reduces complications and readmissions in elderly patients.)\n##\n(\"entity\"<|>STRATTON ET AL.<|>PERSON<|>Stratton et al. performed a meta-analysis evaluating the impact of SNO on hospital admissions and readmissions.)\n##\n(\"entity\"<|>BECK ET AL.<|>PERSON<|>Beck et al. found evidence that the use of SNO in malnourished elderly increases nutritional intake and functional capacity after hospital discharge.)\n##\n(\"entity\"<|>BALLY ET AL.<|>PERSON<|>Bally et al. conducted a meta-analysis reinforcing the benefits of SNO in hospitalized malnourished patients.)\n##\n(\"entity\"<|>NOURISH<|>EVENT<|>The NOURISH study examined the effect of a hyperproteic SNO on malnourished elderly patients, demonstrating a significant reduction in mortality at 90 days.)\n##\n(\"relationship\"<|>PREDYCES<|>ESPAÑA<|>The PREDYCES study highlights the risk of malnutrition among hospitalized patients in Spain<|>8)\n##\n(\"relationship\"<|>EUROPA<|>PREDYCES<|>The PREDYCES study is relevant to the issue of disease-related malnutrition in Europe<|>7)\n##\n(\"relationship\"<|>SNO<|>PREDYCES<|>The PREDYCES study indicates that SNO can improve the nutritional status of patients at risk of malnutrition<|>6)\n##\n(\"relationship\"<|>CAWOOD ET AL.<|>SNO<|>Cawood et al. found that hyperproteic SNO reduces complications in elderly patients<|>7)\n##\n(\"relationship\"<|>STRATTON ET AL.<|>SNO<|>Stratton et al. evaluated the impact of SNO on hospital admissions, showing its effectiveness<|>6)\n##\n(\"relationship\"<|>BECK ET AL.<|>SNO<|>Beck et al. provided evidence that SNO increases nutritional intake in elderly patients<|>6)\n##\n(\"relationship\"<|>BALLY ET AL.<|>SNO<|>Bally et al. reinforced the benefits of SNO in improving outcomes for malnourished patients<|>6)\n##\n(\"relationship\"<|>NOURISH<|>SNO<|>The NOURISH study demonstrated the effectiveness of SNO in reducing mortality among malnourished elderly patients<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: za.\n\n\n\n             La desnutrición relacionada con la enfermedad (DRE) es uno de los principales\n    problemas de salud pública de los países desarrollados debido a su elevada prevalencia\n    y a su asociación con un incremento del riesgo de morbimortalidad y empeoramiento\n    de la calidad de vida del individuo lo que genera un gasto sanitario muy elevado. Se\n    estima que en Europa los costes directos asociados con la DRE ascienden a 170.000\n    millones de euros al año, más del doble del gasto en obesidad.\n\n\n\n             La desnutrición es un problema generalizado en todos los niveles asistenciales y\n    afecta especialmente a ciertos colectivos como son los pacientes geriátricos, oncológi-\n    cos y los crónicos complejos. En el estudio PREDYCES se demostró que la edad, el sexo,\n    la presencia de enfermedades como el cáncer y la diabetes, la disfagia y la polimedica-\n    ción son los principales factores de riesgo asociados al desarrollo de DRE.\n\n\n\n             En Europa se calcula que existen 33 millones de personas en riesgo de desnutri-\n    ción. En nuestro país, según el estudio PREDYCES, el 24% de los pacientes hospitaliza-\n    dos se encuentran en riesgo de desnutrición y esta prevalencia aumenta hasta el 37%\n    en los enfermos mayores de 70 años, el 34% en el paciente oncológico y el 46% en los\n    pacientes con disfagia. En este estudio también se constató un coste adicional de 5829\n    euros por paciente desnutrido lo que permite estimar que el coste potencial de la DRE\n    en España seria de al menos 1143 millones de euros.\n\n\n\n             Actualmente, términos como soporte nutricional especializado o nutrición arti-\n    ficial han sido sustituidos por el concepto de terapia médica nutricional que incluye a\n    los suplementos nutricionales orales (SNO), la nutrición enteral a través de una sonda\n    y la nutrición parenteral.\n\n\n\n             Hay datos suficientes en la literatura que demuestran claramente que la tera-\n    pia médica nutricional, concretamente los SNO, puede mejorar el estado nutricional y\n    funcional, los resultados clínicos y la calidad de vida de los pacientes desnutridos o en\n    riesgo de desnutrición en diferentes niveles asistenciales y que presentan diferentes\n    tipos de patologías. Además también se conoce que la terapia médica nutricional resul-\n    ta coste-efectiva y supone una inversión en salud. Estas evidencias son especialmente\n    concluyente en los ancianos y en los pacientes hospitalizados en plantas médicas con\n    polimorbilidad. Precisamente estos grupos de pacientes son los que consumen una\n    gran parte del tiempo de nuestra asistencia diaria y de los recursos sanitarios.\n\n\n\n16\n---\n         En el caso de los ancianos, Cawood et al. realizaron una revisión sistemática de\n36 ensayos clínicos donde se demostró que los SNO hiperproteicos reducen el riesgo\nde complicaciones y readmisiones hospitalarias, mejoran la capacidad funcional e in-\ncrementan la ingesta proteica y energética. En un metaanálisis de Stratton et al. donde\nse evaluó el impacto de los SNO en relación a las admisiones y readmisiones hospita-\nlarias se concluyó que los SNO reducen de forma significativa el riesgo de reingresos\ntras el alta hospitalaria. En el mismo año, Beck et al., en una revisión sistemática de 6\nensayos clínicos también encontraron evidencia de que el empleo de SNO en ancianos\ndesnutridos aumenta la ingesta nutricional, el peso y la capacidad funcional después\ndel alta hospitalaria. Posteriormente Bally et al. en un metaanálisis de 22 estudios en\npacientes hospitalizados desnutridos refuerza los datos de los anteriores autores en\ntérminos de que los SNO mejoran la ingesta ingesta calórica y energética, la ganancia\nde peso y disminuyen la tasa de reingresos. El estudio NOURISH, un reciente ensayo clí-\nnico multicéntrico examinó el efecto de un SNO hiperproteico enriquecido con beta-hi-\ndroximetilbutirato en 652 ancianos desnutridos hospitalizados con patologías crónicas\ndemostrando que los SNO reducen de forma significativa la mortalidad a los 90 días.\n\n\n\n         Además de los ancianos, en otros grupos de pacientes también se han eviden-\nciado los beneficios de los SNO. Elia et al., publicaron dos revisiones sistemáticas y me-\ntaanálisis referentes al empleo de los SNO en pacientes comunitarios y hospitalizados\npor diferentes patologías. Dichos autores constataron que los pacientes hospitalizados\nen plantas médicas, quirú\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}